Cookie Policy - To find out more about cookies on this website, see our privacy policy

Cookie Policy

We Help Companies Find New Sales Opportunities

We Help Companies Find New Sales Opportunities

Dechra Pharmaceuticals

Dechra Pharmaceuticals is setting up a new 3,000 sq ft headquarters on the Cheshire Business Park in Northwich.

Dechra Pharmaceuticals is to acquire Eurovet Animal Health, the Dutch veterinary pharmaceuticals supplier with a site in Cambridge, from AUV Holding for £112m.

Dechra Pharmaceuticals has acquired Genitrix, the Billingshurst-based veterinary pharmaceuticals company, for an initial £5.4m.

Dechra Pharmaceuticals is to acquire DermaPet, the US supplier of dermatological preparations for animals, for £40m.

Dechra is to invest £1m in the expansion of its animal medicines site in Talke, North Staffordshire, including a new warehouse on the Jamage Industrial Estate.

Dechra Pharmaceuticals is planning to acquire VetXX, the Danish supplier of veterinary products with 165 staff, for £62m.

Dechra Pharmaceuticals has acquired Leeds Veterinary Laboratories, the Leeds-based supplier of veterinary diagnostic tests with 18 staff, for £0.8m.

Dechra Pharmaceuticals has acquired Anglian Pharma of Lincolnshire for £2.5m, and will merge the business with its Dales pharmaceutical contract manufacturing business in Skipton.

Dechra Pharmaceuticals is to acquire North Western Laboratories of Lancashire and its Cambridge Specialist Laboratory Services subsidiary for £2.8m, in order to expand its veterinary pharmaceuticals business.

Dechra Pharmaceuticals is planning a £2m expansion at its veterinary products factory in Skipton over the next 18 months.